These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 185040)

  • 1. Drug-induced hypertension: pathogenesis and management.
    Stokes GS
    Drugs; 1976; 12(3):222-30. PubMed ID: 185040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
    Hollenberg NK; Williams GH; Burger B; Chenitz W; Hoosmand I; Adams DF
    Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure changes and hormonal contraceptives.
    Shen Q; Lin D; Jiang X; Li H; Zhang Z
    Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraceptives, hypertension and nephrosclerosis].
    Girndt J
    Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathogenesis of oral contraceptive hypertension (author's transl)].
    Girndt J; Scheler F
    Klin Wochenschr; 1977 Apr; 55(7):347-8. PubMed ID: 870746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
    Meade TW
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
    Weir RJ
    Scott Med J; 1982 Jul; 27(3):212-5. PubMed ID: 6810459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogens and hypertension.
    Roberts JM
    Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
    Shionoiri H; Eggena P; Barrett JD; Thananopavarn C; Golub MS; Eggena Z; Nakamura R; Judd HL; Sambhi MP
    Biochem Med; 1983 Feb; 29(1):14-22. PubMed ID: 6838497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.